These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27125717)

  • 21. Efficacy of 5-ASA in the treatment of colonic diverticular disease.
    Gatta L; Vakil N; Vaira D; Pilotto A; Curlo M; Comparato G; Leandro G; Ferro U; Lera M; Milletti S; Di Mario F
    J Clin Gastroenterol; 2010 Feb; 44(2):113-9. PubMed ID: 19561530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term treatment with mesalazine in patients with symptomatic uncomplicated diverticular disease.
    Gatta L; Di Mario F; Curlo M; Vaira D; Pilotto A; Lucarini P; Lera M; Enkleda K; Franzé A; Scarpignato C
    Intern Emerg Med; 2012 Apr; 7(2):133-7. PubMed ID: 21279478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diverticular disease of the colon.
    Tursi A
    Lancet; 2004 Apr; 363(9418):1397-8. PubMed ID: 15110505
    [No Abstract]   [Full Text] [Related]  

  • 24. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Treatment of Left-Sided Colonic Diverticulitis.
    Hall J; Hardiman K; Lee S; Lightner A; Stocchi L; Paquette IM; Steele SR; Feingold DL;
    Dis Colon Rectum; 2020 Jun; 63(6):728-747. PubMed ID: 32384404
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical inquiries: How can you help prevent a recurrence of diverticulitis?
    Weisberger L; Jamieson B
    J Fam Pract; 2009 Jul; 58(7):381-2. PubMed ID: 19607778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances in the management of colonic diverticulitis.
    Tursi A
    CMAJ; 2012 Sep; 184(13):1470-6. PubMed ID: 22927512
    [No Abstract]   [Full Text] [Related]  

  • 27. Randomised clinical trial: mesalazine versus placebo in the prevention of diverticulitis recurrence.
    Kruis W; Kardalinos V; Eisenbach T; Lukas M; Vich T; Bunganic I; Pokrotnieks J; Derova J; Kondrackiene J; Safadi R; Tuculanu D; Tulassay Z; Banai J; Curtin A; Dorofeyev AE; Zakko SF; Ferreira N; Björck S; Diez Alonso MM; Mäkelä J; Talley NJ; Dilger K; Greinwald R; Mohrbacher R; Spiller R
    Aliment Pharmacol Ther; 2017 Aug; 46(3):282-291. PubMed ID: 28543263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Balsalazide and/or high-potency probiotic mixture (VSL#3) in maintaining remission after attack of acute, uncomplicated diverticulitis of the colon.
    Tursi A; Brandimarte G; Giorgetti GM; Elisei W; Aiello F
    Int J Colorectal Dis; 2007 Sep; 22(9):1103-8. PubMed ID: 17390144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Once-daily mesalamine (Lialda) for ulcerative colitis.
    Med Lett Drugs Ther; 2007 Mar; 49(1257):25-6. PubMed ID: 17375030
    [No Abstract]   [Full Text] [Related]  

  • 30. [Modern indications on the medical treatment of symptomatic diverticular disease].
    Ierfone N; Di Fulvio A; Pontone S; Terzakis P; Martino G; Pontone P
    G Chir; 2006 Mar; 27(3):93-6. PubMed ID: 16681868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The mesalamine wars heat up-enter balsalazide.
    Cohen RD
    Gastroenterology; 2003 Feb; 124(2):574-5. PubMed ID: 12557164
    [No Abstract]   [Full Text] [Related]  

  • 32. Diverticular disease as a chronic illness: evolving epidemiologic and clinical insights.
    Strate LL; Modi R; Cohen E; Spiegel BM
    Am J Gastroenterol; 2012 Oct; 107(10):1486-93. PubMed ID: 22777341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diverticulosis/diverticulitis? What are conservative therapy possibilities?].
    Rinas U; Adamek HE
    Med Klin (Munich); 2006 Jan; 101(1):49-57; quiz 58-9. PubMed ID: 16418814
    [No Abstract]   [Full Text] [Related]  

  • 34. The hair of the dog.
    Bahrani O
    Am J Gastroenterol; 2001 Sep; 96(9):2789-90. PubMed ID: 11569714
    [No Abstract]   [Full Text] [Related]  

  • 35. Prevention and treatment of postoperative Crohn's disease recurrence with anti-TNF therapy: a meta-analysis of controlled trials.
    Carla-Moreau A; Paul S; Roblin X; Genin C; Peyrin-Biroulet L
    Dig Liver Dis; 2015 Mar; 47(3):191-6. PubMed ID: 25488057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expanding applications: the potential usage of 5-aminosalicylic acid in diverticular disease.
    Tursi A; Joseph RE; Streck P
    Dig Dis Sci; 2011 Nov; 56(11):3112-21. PubMed ID: 21567193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Modern therapy of diverticular disease].
    Leifeld L; Kruis W
    Internist (Berl); 2008 Dec; 49(12):1415-6, 1418-20. PubMed ID: 18946642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. American Gastroenterological Association Institute Guideline on the Management of Acute Diverticulitis.
    Stollman N; Smalley W; Hirano I;
    Gastroenterology; 2015 Dec; 149(7):1944-9. PubMed ID: 26453777
    [No Abstract]   [Full Text] [Related]  

  • 39. [Ulcerative colitis. Acute episode].
    Reissmann A; Bischoff SC; Fleig W
    Z Gastroenterol; 2004 Sep; 42(9):994-8. PubMed ID: 15455271
    [No Abstract]   [Full Text] [Related]  

  • 40. Management of diverticular disease is changing.
    Floch MH; White JA
    World J Gastroenterol; 2006 May; 12(20):3225-8. PubMed ID: 16718843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.